Tag: DETOUR2
Three-year DETOUR2 results demonstrate sustained limb preservation in complex SFA disease
Endologix has announced publication of 36-month results from the DETOUR2 clinical trial evaluating percutaneous transmural arterial bypass (PTAB) using the Detour system in the...
Endologix announces 36-month results of DETOUR2 study
Endologix has announced the final 36-month results from the DETOUR2 study—a prospective, single-arm, international, multicentre clinical evaluation of the novel Detour system for fully...
Two-year DETOUR2 study results presented at VAM 2023
Endologix has announced the 24-month results of the DETOUR2 study, presented at VAM 2023 (14–17 June, National Harbor, USA), the annual meeting of the...
